Glucocerebrosidase Treatment of Type I Gaucher Disease with Severe Pulmonary Involvement

  1. Michael Pelini, MD;
  2. Douglas Boice*, MD;
  3. Kevin O'Neil, MD; and
  4. James LaRocque, MD
  1. From the Naval Medical Center, Portsmouth, Virginia. Requests for Reprints: LCDR Kevin O'Neil, MC, Pulmonary Division, Ward 5A, Naval Medical Center, 620 John Paul Jones Circle, Portsmouth, VA 23708-5100. Disclaimer: The opinions expressed are those of the authors and do not represent those of the Navy or the Department of Defense.

    Abstract

    *Deceased.

    « Previous | Next Article »Table of Contents